Cipla launches generic Idiopathic Pulmonary Fibrosis drug Nintedanib in India Ruchika Sharma21 Oct 2020 1:00 PM ISTNew Delhi: Pharma major Cipla on Tuesday said it has launched generic Nintedanib used for the treatment of Idiopathic Pulmonary Fibrosis (IPF) under...
NPPA fixes retail price of 26 formulations; Details Farhat Nasim30 Sept 2020 3:51 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India...
Cipla gets USFDA nod for Dimethyl Fumarate DR Capsules to treat multiple sclerosis Ruchika Sharma27 Sept 2020 10:00 AM ISTMumbai: Drugmaker, Cipla Limited, has recently announced that the company has received final approval for its Abbreviated New Drug Application...
CDSCO commmitee nod to Cipla, Optimus phase 4 trials of COVID drug favipiravir Farhat Nasim11 Sept 2020 3:00 PM ISTNew Delhi: Drug major Cipla Ltd and Optimus Pharma have recently secured permission from the expert's panel of Central Drugs Standard Control...
Cipla, Stempeutics join hands for critical limb ischemia treatment in India Ruchika Sharma21 Aug 2020 12:14 PM ISTThe product is indicated for the treatment of CLI due to Buerger''s disease and atherosclerotic peripheral arterial disease, it added.
Cipla collaborating with CSIR, IICT, ICMR, Health Ministry to develop treatment for COVID-19 Ruchika Sharma6 Aug 2020 2:07 PM ISTNew Delhi: Drug major Cipla is working with government agencies to develop a treatment for COVID-19 while ramping up the production of various...
Mega Exit: Cipla India top boss, 2 senior executives step out after 24 year stint Farhat Nasim5 Aug 2020 12:45 PM ISTMumbai: The sudden exit of top executives of drug major Cipla Ltd. has come as a major shock; wherein; Nikhil Chopra, the company's chief executive of...
Cipla to launch affordable COVID-19 drug Favipiravir Ruchika Sharma24 July 2020 12:50 PM ISTAn off-patent anti-viral drug, Favipiravir, originally discovered by Fuji Pharma in Japan, has shown promise in clinical trials for the treatment of...
Cipla settles case with Amgen involving generic Cinacalcet Hydrochloride Tablets Ruchika Sharma22 July 2020 2:19 PM ISTNew Delhi: The drug major has reached a settlement with Amgen Inc on pending litigation involving generic cinacalcet hydrochloride tablets. The civil...
Cipla gets USFDA nod to generic version of Firazyr Ruchika Sharma14 July 2020 11:52 AM ISTIcatibant injection is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older.
Ensure production, adequate stock of methylprednisolone, heparin, dexamethasone: NPPA directs pharma cos Ruchika Sharma10 July 2020 4:49 PM ISTNew Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA) has directed State Drug Controllers (SDCs) to...
Cipla launches Cipremi at Rs 4,000 per vial Ruchika Sharma9 July 2020 12:07 PM IST"We are proud to commercially launch Cipremi today (on Wednesday); amongst the lowest priced globally, and aim to supply over 80,000 vials within the...
